Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1783-1786

  DesJardin, Jeffrey A ^a   Gibbons, Laurie ^a   Cho, Eunhui ^a   Supran, Stacey E ^a   Falagas, Matthew E ^a   Werner, Barbara G ^a   Snydman, David R ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS REACTIVATION;

ADULT; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEPATITIS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; KIDNEY TRANSPLANTATION; MALE; NEUTROPENIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRUS ACTIVATION;

EID: 0031736086     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314510     Document Type: Article

References (15)

1. Dockrell DH, Prada J, Jones MF, et al. Seroconversion of human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997;176:1135-40.
2. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996;22:171-3.
3. Okuno T, Higashi K, Shiraki K, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990;49:519-22.
4. Yoshikawa T, Suga S, Asano Y, et al. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 1992;54:879-83.
5. Morris DJ, Littler E, Arrand JR, Jordan D, Mallick NP, Johnson RWB. Human herpesvirus 6 infection in renal transplant recipients [letter]. N Engl J Med 1989;320:1560-1.
6. Chapman JR, Ratnamohan VM, Howse H, et al. Viral disease after OKT3/ATG is due to either HHV6 or CMV or both [abstract 235]. In: Abstracts of the 16th International Congress of the Transplantation Society (Barcelona, Spain). Stony Brook, NY: ICTS, 1996:382.
7. Lautenschlager I, Höckerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998;26:702-7.
8. Snydman DR, Werner BG, Heinze-Lacey B, et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987;317:1049-54.
9. Flamand L, Gosselin J, D'Addario M, et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 1991;65:5105-10.
10. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995;85:1263-71.
11. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992;165:925-9.
12. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
13. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994;84:3307-10.
14. Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient. Clin Infect Dis 1996;22:174-5.
15. Kadakia MP, Rybka WB, Stewart JA, et al. Human herpesvirus-6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996;87:5341-54.